Today's episode covers groundbreaking advancements in the fields of biopharmaceuticals, cancer screening diagnostics, and hydrological science. RedHill Biopharma and Apogee Biotechnology Corp. are making strides in developing opaganib as a potential treatment for diabetes and obesity-related disorders. Meanwhile, companies like Exact Sciences, Guardant Health Inc., Illumina Inc., and Ludwig Enterprises Inc. are leading the way in early cancer screening tests. Lastly, researchers from Yunnan University and Pennsylvania State University have developed a transfer learning model to improve daily streamflow forecasts, particularly in data-scarce regions like the Dulong-Irrawaddy River Basin.